Gunewardena S

No ORCID on file · 6 papers in corpus · active 2016-2024
2024
Cell death & disease ·doi:10.1038/s41419-024-06717-3

Advanced epithelial ovarian cancer (EOC) survival rates are dishearteningly low, with ~25% surviving beyond 5 years. Evidence suggests that cancer stem cells contribute to acquired chemoresistance and tumor recurrence. Here, we show that IR…

2024
The Journal of clinical investigation ·doi:10.1172/jci163796

Proper action of the female sex steroids 17β-estradiol (E2) and progesterone (P4) on the endometrium is essential for fertility. Beyond its role in regulating the cell cycle, cyclin A2 (CCNA2) also mediates E2 and P4 signaling in vitro, but…

2022
BMC cancer ·doi:10.1186/s12885-022-09280-2

BackgroundBreast cancer is the most common malignancy in women, and is both pathologically and genetically heterogeneous, making early detection and treatment difficult. A subset of breast cancers express normal levels of REST (repressor el…

2018
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-018-1239-9

PurposeThe study aims to determine differences in micro-RNA (miRNA) expression in granulosa (GC) and cumulus cells (CC) between young women with diminished ovarian reserve (DOR) or normal ovarian reserve (NOR). Secondary objective was to id…

2017
Molecular reproduction and development ·doi:10.1002/mrd.22856

Blood-borne extracellular vesicles (i.e., exosomes and microvesicles) carrying microRNAs (miRNAs) could make excellent biomarkers of disease and different physiologic states, including pregnancy status. We tested the hypothesis that circula…

2016
Scientific reports ·doi:10.1038/srep25486

Exosomes and microvesicles (i.e., extracellular vesicles: EVs) have been identified within ovarian follicular fluid and recent evidence suggests that EVs are able to elicit profound effects on ovarian cell function. While existence of miRNA…